Cellular Immunity Abnormalities in Patients with Recurrent Bell's Palsy
Overview
Affiliations
Recurrent Bell's palsy is a rare form of facial paralysis. To investigate the role which cellular immunity plays in the aetiology of recurrent Bell's palsy, we evaluated a series of such patients using a laboratory test specially formulated to test the cellular immune system. We measured T-lymphocyte and T-lymphocyte subsets in the peripheral blood of 10 recurrent Bell's palsy patients and in 30 healthy volunteers. T-lymphocytes and T-lymphocyte subsets were reduced significantly in the patients, but the T-helper: T-cytotoxic ratio was normal. Cellular immunity abnormalities were therefore found in the peripheral blood of patients with recurrent Bell's palsy, supporting the concept that this is an immunomediated demyelinating disease.
Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021-2022.
Yoon D, Jung K, Kim J, Ko H, Yoon B, Shin J Emerg Infect Dis. 2024; 30(11):2313-2322.
PMID: 39378869 PMC: 11521192. DOI: 10.3201/eid3011.240610.
Jin F, Yu E, Chen J, Zhou W, Cai H, Hu J Eur Arch Otorhinolaryngol. 2023; 281(5):2293-2301.
PMID: 38015248 DOI: 10.1007/s00405-023-08340-y.
Increased risk of cancer after Bell's palsy: a 5-year follow-up study.
Sheu J, Keller J, Lin H J Neurooncol. 2012; 110(2):215-20.
PMID: 22890970 DOI: 10.1007/s11060-012-0954-9.